0001415889-22-010651.txt : 20221018 0001415889-22-010651.hdr.sgml : 20221018 20221018170101 ACCESSION NUMBER: 0001415889-22-010651 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221014 FILED AS OF DATE: 20221018 DATE AS OF CHANGE: 20221018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dake Benjamin T CENTRAL INDEX KEY: 0001869248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 221316458 MAIL ADDRESS: STREET 1: C/O AEROVATE THERAPEUTICS, INC. STREET 2: 200 BERKELEY STREET, FLOOR 18 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-10182022_051001.xml X0306 4 2022-10-14 0001798749 Aerovate Therapeutics, Inc. AVTE 0001869248 Dake Benjamin T C/O AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451 false true false false SEE REMARKS Common Stock 2022-10-14 4 M 0 110 2.14 A 110 D Common Stock 2022-10-14 4 S 0 110 20.05 D 0 D Common Stock 2022-10-17 4 M 0 4185 2.14 A 4185 D Common Stock 2022-10-17 4 S 0 4185 20.1624 D 0 D Stock Option (Right to Buy) 2.14 2022-10-14 4 M 0 110 0 D 2031-04-01 Common Stock 110 309056 D Stock Option (Right to Buy) 2.14 2022-10-17 4 M 0 4185 0 D 2031-04-01 Common Stock 4185 304871 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.602, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments. Officer Title: President, Chief Operating Officer and Secretary /s/ George A Eldridge, Attorney-in-Fact 2022-10-18